Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class ASSE: 600196

Indicative Announcement on Obtaining EU Approval of a New Indication for a Drug Developed by the Holding Subsidiary

· Issued by Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A via Shanghai Stock Exchange
Indicative Announcement on Obtaining EU Approval of a New Indication for a Drug Developed by the Holding Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment